Is there a replay of the KOL talk? I was not able to catch it today.
Great to hear the CEO is excited and confident! I really like Dror.
Question: Did the KOL specifically express enthusiasm for an anti-PDL1, as opposed to an anti-PD1? If so, did they say why? Remember, PDL1 and PDL2 are both ligands of PD1.